This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hurley, J C Search for Related Content PubMed PubMed Citation Articles by Hurley, J C

Concordance of endotoxemia with gram-negative bacteremia in patients with gram-negative sepsis: a meta-analysis.

Division of Infectious Diseases, Children's Hospital & Medical Center, Seattle, Washington 98105-0371.

ABSTRACT

The Limulus amebocyte lysate (LAL) assay is a sensitive method for detecting endotoxin. Using gram-negative (GN) bacteremia as the basis for comparison, concordance with endotoxemia in 45 studies could be expressed as an odds ratio. Calculation of summary odds ratios by the Mantel-Haenszel-Peto method indicated that the concordance of the results was no higher by the chromogenic LAL assay than by the gelation version, and the sensitivity was improved by only 11% (62 versus 51%). Endotoxemia was detected in 77 (68%) of 114 patients with bacteremia caused by an organism that was not a member of the family Enterobacteriaceae, whereas endotoxemia was detected in only 120 (45%) of 269 patients with bacteremia caused by a member of the family Enterobacteriaceae or an anaerobe (P < 0.001). This difference was also apparent for patients with GN bacteremia for whom a fatal outcome had been recorded. The prevalence of GN bacteremia in the tested population and the type of etiological agent are critical and previously unrecognized variables which affect the interpretation of the LAL test in patients with suspected sepsis.

This article has been cited by other articles:

• Hurley, J. C. (2003). Endotoxemia and Gram-negative bacteremia as predictors of outcome in sepsis: a meta-analysis using ROC curves. Innate Immunity 9: 271-279 [Abstract]  
• Beno, D. W. A., Uhing, M. R., Goto, M., Chen, Y., Jiyamapa-Serna, V. A., Kimura, R. E. (2001). Staphylococcal enterotoxin B potentiates LPS-induced hepatic dysfunction in chronically catheterized rats. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G866-G872 [Abstract] [Full Text]  
• NOVITSKY, T. J. (1998). Limitations of the Limulus Amebocyte Lysate Test in Demonstrating Circulating Lipopolysaccharides. Ann. N. Y. Acad. Sci. 851: 416-421 [Full Text]  
• Ketchum, P.A., Parsonnet, J., Stotts, L.S., Novitsky, T.J., Schlain, B., Bates, D.W., AMCC SEPSIS Project, (1997). Utilization of a chromogenic Limulus amebocyte lysate blood assay in a multi-center study of sepsis. Innate Immunity 4: 9-16 [Abstract]  
• Holzheimer, R.G., Hirte, J.F., Reith, B., Engelhardt, W., Horak, K.H., Leppert, R., Aasen, A., Capel, P., Urbaschek, R., Karch, H., Thiede, A. (1996). Different endotoxin release and IL-6 plasma levels after antibiotic administration in surgical intensive care patients. Innate Immunity 3: 261-267 [Abstract]  
• Ng, K.P., Bhanumathy, M., Ong, G.S.Y., Yong, B.H., Parasakthi, N., Koh, M.T., Siow, C.P., Bosco, J. (1995). Endotoxin tests in patients with sepsis. Innate Immunity 2: 387-393 [Abstract]  
• Novitsky, T.J. (1994). Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. Innate Immunity 1: 253-263 [Abstract]